Investments Cytokinetics maintains $99 target on positive trial data By Investing.com – Investing.com Last updated: 2024/04/07 at 7:03 PM By Editor 0 Min Read Share SHARE Cytokinetics maintains $99 target on positive trial data By Investing.com Investing.comsource You Might Also Like Earnings call: Air France-KLM reports steady growth amid challenges – Investing.com Earnings call: Pason Systems posts solid Q1 despite market challenges – Investing.com Earnings call: Gerdau reports Q1 2024 results, plans Mexico investment – Investing.com What will the Fed do after Friday's jobs report? By Investing.com – Investing.com Procept BioRobotics director sells $1.2 million in company stock – Investing.com TAGGED: Articles Editor April 7, 2024 April 7, 2024 Share This Article Facebook Twitter Email Print Previous Article Business News Highlights: Stock Market Closes, Sensex Gains 336 Points, Nifty At 22,151 – ABP Live Next Article Hina Khan performs Umrah in Mecca during Ramadan: “When god wills, fates align and dreams turn into realities” – Bollywood Hungama Leave a comment Leave a Reply Cancel reply Connect with: Your email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay Connected Facebook Like Twitter Follow Youtube Subscribe Telegram Follow - Advertisement - Latest News Earnings call: Air France-KLM reports steady growth amid challenges – Investing.com Investments Earnings call: Pason Systems posts solid Q1 despite market challenges – Investing.com Investments Earnings call: Gerdau reports Q1 2024 results, plans Mexico investment – Investing.com Investments What will the Fed do after Friday's jobs report? By Investing.com – Investing.com Investments